A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076



Status:Completed
Conditions:Overactive Bladder
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:5 - 17
Updated:11/18/2018
Start Date:October 4, 2012
End Date:October 8, 2014

Use our guide to learn which trials are right for you!

An Open-Label, Long-Term Extension, Multi-center, Sequential Dose Titration Study to Assess Safety and Efficacy of Solifenacin Succinate Suspension in Pediatric Subjects With Overactive Bladder (OAB)

This was a 40-week study to investigate how safe and effective solifenacin solution was in
treating children or adolescents with symptoms of overactive bladder (OAB), who completed
study 905-CL-076 (NCT01565707).

There was a titration period of up to 12 weeks during which the participants would be up or
down-titrated based on a combination of efficacy and safety parameters followed by a fixed
dose period during which no dose adjustments were allowed. Participants completed a 7-day
patient diary prior to every visit (start of 905-CL-076 to end of 905-CL-077, 14 visits). The
first visit of this study (905-CL-077) was combined with the last visit of the 4-month study
905-CL-076. At each visit, the participant was required to undertake a number of assessments
or examinations to determine whether it is safe for him/her to take part or to continue to
take part in the study.

Inclusion Criteria:

- Subject has met the inclusion criteria of study 905-CL-076 and completed study
905-CL-076

Exclusion Criteria:

- Subject has failed the exclusion criteria of study 905-CL-076
We found this trial at
2
sites
?
mi
from
Shreveport, LA
Click here to add this to my saved trials
?
mi
from
Antwerp,
Click here to add this to my saved trials